Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict.
The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case comes just five weeks after the Justice Department filed a similar lawsuit against OhioHealth.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracts that force insurers to include all of its hospitals and physicians. The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.
Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical information. Epic denied the claims — but the lawsuit highlights ongoing concerns about interoperability, data access and competition in the healthcare software space.
Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk would violate U.S. antitrust law. Metsera called the arguments “nonsense” and said Pfizer is trying to buy the obesity drug developer for less than what Novo is willing to pay.
A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic’s alleged use of its influence over the Carequality data exchange to block Particle’s access to patient records and stifle competition in the emerging payer platform market.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer.
Following a months-long dispute, data platform Particle Health filed an antitrust lawsuit against Epic, alleging that the EHR giant is using its dominance in the market to prevent competition in the payer platform space. Particle believes the lawsuit is an “unprecedented challenge” to Epic’s market power, while Epic thinks the startup’s claims are “baseless.”
Algorithms make it possible for companies to fix prices without explicitly coordinating with one another, posing a new test for regulators policing the market, said Lina Khan, chair of the Federal Trade Commission, during a media event hosted by KFF.
The U.S. Department of Justice has reportedly recently launched an antitrust investigation of UnitedHealth Group, which begs the question of whether the healthcare giant should be broken up. Experts have varying opinions.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Illumina has decided against further appeals of U.S. and European antitrust litigation challenging its acquisition of liquid biopsy company Grail. Illumina expects to have terms of the divestiture set by the end of the second quarter of 2024.
A group of labor unions have filed an antitrust complaint against UPMC. They alleged that the health system has prevented its workers from being able to advocate for themselves and their patients through “a draconian system of mobility restrictions and widespread labor law violations that lock in sub-competitive pay and working conditions.”
Combining the two companies may give UnitedHealth unfair access to its competitors data that is operated by Change Healthcare, the DOJ warned it its complaint, but a DC judge has blocked the complaint.
Attorney General Letitia James accused CVS of a scheme starting in 2017 to prevent New York safety net hospitals from using the company of their choice to obtain federal drug subsidies on prescriptions filled at CVS through the 340B program
The Department of Justice filed the lawsuit in the U.S. District Court for the District of Columbia to stop the deal just ahead of it being finalized on February 27.